TrialSieve: A Comprehensive Biomedical Information Extraction Framework for PICO, Meta-Analysis, and Drug Repurposing.

This work introduces TrialSieve, a novel framework for biomedical information extraction that enhances clinical meta-analysis and drug repurposing. By extending traditional PICO (Patient, Intervention, Comparison, Outcome) methodologies, TrialSieve incorporates hierarchical, treatment group-based graphs, enabling more comprehensive and quantitative comparisons of clinical outcomes. TrialSieve was used to annotate 1609 PubMed abstracts, 170,557 annotations, and 52,638 final spans, incorporating 20 unique annotation categories that capture a diverse range of biomedical entities relevant to systematic reviews and meta-analyses.

Restoring Homeostasis: Treating Amyotrophic Lateral Sclerosis by Resolving Dynamic Regulatory Instability.

Amyotrophic lateral sclerosis (ALS) has an interactive, multifactorial etiology that makes treatment success elusive. This study evaluates how regulatory dynamics impact disease progression and treatment. Computational models of wild-type (WT) and transgenic SOD1-G93A mouse physiology dynamics were built using the first-principles-based first-order feedback framework of dynamic meta-analysis with parameter optimization.

BioSift: A Dataset for Filtering Biomedical Abstracts for Drug Repurposing and Clinical Meta-Analysis.

This work presents a new, original document classification dataset, BioSift, to expedite the initial selection and labeling of studies for drug repurposing. The dataset consists of 10,000 human-annotated abstracts from scientific articles in PubMed. Each abstract is labeled with up to eight attributes necessary to perform meta-analysis utilizing the popular patient-intervention-comparator-outcome (PICO) method: has human subjects, is clinical trial/cohort, has population size, has target disease, has study drug, has comparator group, has a quantitative outcome, and an "aggregate" label.

TOWARDS INTERPRETABLE SEIZURE DETECTION USING WEARABLES.

Seizure detection using machine learning is a critical problem for the timely intervention and management of epilepsy. We propose SeizFt, a robust seizure detection framework using EEG from a wearable device. It uses features paired with an ensemble of trees, thus enabling further interpretation of the model's results.

An Interpretable Machine Learning Framework for Rare Disease: A Case Study to Stratify Infection Risk in Pediatric Leukemia.

: Datasets on rare diseases, like pediatric acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), have small sample sizes that hinder machine learning (ML). The objective was to develop an interpretable ML framework to elucidate actionable insights from small tabular rare disease datasets. : The comprehensive framework employed optimized data imputation and sampling, supervised and unsupervised learning, and literature-based discovery (LBD).

SeizFt: Interpretable Machine Learning for Seizure Detection Using Wearables.

This work presents SeizFt-a novel seizure detection framework that utilizes machine learning to automatically detect seizures using wearable SensorDot EEG data. Inspired by interpretable sleep staging, our novel approach employs a unique combination of data augmentation, meaningful feature extraction, and an ensemble of decision trees to improve resilience to variations in EEG and to increase the capacity to generalize to unseen data. Fourier Transform (FT) Surrogates were utilized to increase sample size and improve the class balance between labeled non-seizure and seizure epochs.